BRITTANIA PHILLIPS: Open Payments
NPI 1174294789 · SAINT PETERS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 36 payments from 12 companies in 2025. Trend: 2023 $891 · 2024 $767 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $89 |
| ABBVIE INC. | 4 | $71 |
| Alkermes, Inc. | 3 | $57 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REXULTI, CAPLYTA, VRAYLAR, ARISTADA, Qelbree, COBENFY, INGREZZA, FANAPT.
Industry payments across MO — which companies pay providers there.
